Showing results (21-30 of 64) with videos related to
Sort By:
Pageof 7
The British Journal of Nutrition|November 10, 2021
The feasibility of a peer support intervention to encourage adoption and maintenance of a Mediterranean diet in established community groups at increased CVD risk: the TEAM-MED EXTEND study: a pilot cluster randomised controlled trialRoisin F O'Neill, Laura McGowan, Claire T McEvoy, et al.MMWR. Morbidity and Mortality Weekly Report|January 17, 2020
Update: Product, Substance-Use, and Demographic Characteristics of Hospitalized Patients in a Nationwide Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injury - United States, August 2019-January 2020Sascha Ellington, Phillip P Salvatore, Jean Ko, et al.MMWR. Morbidity and Mortality Weekly Report|January 11, 2024
Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing COVID-19-Related Thromboembolic Events Among Medicare Enrollees Aged ≥65 Years and Those with End Stage Renal Disease - United States, September 2022-March 2023Amanda B Payne, Shannon Novosad, Ryan E Wiegand, et al.MMWR. Morbidity and Mortality Weekly Report|May 15, 2020
Public Health Response to COVID-19 Cases in Correctional and Detention Facilities - Louisiana, March-April 2020Megan Wallace, Mariel Marlow, Sean Simonson, et al.MMWR. Morbidity and Mortality Weekly Report|June 15, 2023
Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months - United States, April 2023Danielle L Moulia, Megan Wallace, Lauren E Roper, et al.BMC Medical Education|May 21, 2025
Research training curriculum and projects undertaken by medical students in Australia and new ZealandJoanne Hart, Adam Collison, Jon Cornwall, et al.Vaccine|January 31, 2025
Estimating COVID-19 associated hospitalizations, ICU admissions, and in-hospital deaths averted in the United States by 2023-2024 COVID-19 vaccination: A conditional probability, causal inference, and multiplier-based approachRyan E Wiegand, Owen Devine, Megan Wallace, et al.Vaccine|August 1, 2023
A summary of the Advisory Committee for Immunization Practices (ACIP) use of a benefit-risk assessment framework during the first year of COVID-19 vaccine administration in the United StatesMegan Wallace, Hannah G Rosenblum, Danielle L Moulia, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 21, 2025
Effectiveness of Bivalent mRNA COVID-19 Vaccine Among Adults With Kidney Failure Receiving Dialysis: A Cohort Study From the Centers for Medicare and Medicaid ServicesAmanda B Payne, Shannon Novosad, Heng-Ming Sung, et al.Vaccine|April 4, 2025
Effectiveness of 2023-2024 COVID-19 vaccines against COVID-19-associated hospitalizations among adults aged ≥18 years with end stage kidney disease - United States, September 2023-April 2024Amanda B Payne, Shannon Novosad, Heng-Ming Sung, et al.Pageof 7